Newsroom

JULY 2020 JACQUELINE LISK Data and AI are transforming science and reducing health care costs. Moore’s Law states the speed and capabilities of computers will increase every couple of years, but their cost will continue to go down. John Sculley, a business leader, speaker, and author who served as CEO of Apple from 1983 to 1993, notes we live in a word in which biology is technology and, as...

JUNE 2020 ELIZA SKOLER, JIMMY MCDERMOTT, MATTHEW GARZA, DIVYA GOPISETTY, FRIDA VELCANI, EMILY FITTS, KARENA YAN, JOSEPH BELL, LORENA BERGSTROM, AND ROSALIND LUCIER The Biggest News in Diabetes Technology, Drugs, and Nutrition: Highlights from ADA 2020 An exciting study examined the success of the Glucommander insulin dosage software for people with type 2 diabetes on multiple daily injections...

JUNE 2020 ROBBY BOOTH 5 Reasons Why Providers Need Electronic Support for Glycemic Management It’s no secret hyperglycemia and hypoglycemia are associated with adverse outcomes in hospitalized patients. We’ve known for many years that hyperglycemia is widespread in the hospital, causes immune dysfunction, higher rates of infection, a longer length of hospital stay, complications, and even death. ...

JUNE 2020 PATRICK CAMPBELL Bruce Bode, MD: Impact of COVID-19 on Diabetes Care and Endocrinology The impact of the coronavirus disease 2019 (COVID-19) outbreak on endocrinology has been impossible to ignore. With diabetic patients at increased risk of developing serious complications, endocrinologists have had to keep a keen eye on the latest on the disease for the wellbeing of their patients....

JUNE 2020 DAVE MUOIO Onduo, Medtronic, Abbott, Glytec present diabetes management study data at ADA 2020 virtual conference From virtual management programs to hybrid closed loop systems, diabetes management companies put the spotlight on improved blood glucose management and positive clinical outcomes. The American Diabetes Association's 80th Scientific Sessions kicked off this weekend, and a...

First study to utilize CGM data with FDA-cleared, cloud-based titration software suggests significantly improved outcomes for patients while optimizing clinical resources WALTHAM, MASS. (June 16, 2020) – Glytec, the only provider of insulin management software across the continuum of care, today published the first proof-of-concept study that combines FDA-cleared remote insulin titration...

JUNE 2020 PATRICK CAMPBELL Preventing Hypoglycemia, Hyperglycemia with Insulin and Glucagon Coadministration Attempting to prevent hypoglycemia without worsening hyperglycemia in those with type 1 diabetes has been a challenge for clinicians for decades, but results of a new study from the American Diabetes Association’s (ADA) 80th Scientific Sessions signal there could be a change on the horizon.

Event Includes Six Studies on Quality and Cost Improvements Achieved Through Glytec eGMS® WALTHAM, MASS. (June 11, 2020) – Glytec, the only provider of insulin management software across the continuum of care, announced today that healthcare providers from five separate health systems will present studies on the transformative effects of implementing its eGlycemic Management System (eGMS) during...

MAY 2020

APRIL 27, 2020 Eleanor McDermid Uncontrolled hyperglycemia might be COVID-19 mortality risk factor medwireNews: A descriptive analysis of US patients with COVID-19 reports a high in-hospital mortality rate in those with uncontrolled hyperglycemia. The rate was markedly higher than that seen in patients with confirmed diabetes, although Valerie Garrett (Glytec Inc., Waltham, Massachusetts, USA)...